Leading Global Investor in Energy, Innovation and Efficiency LP CONNECTION

IT/Healthcare

Neuraltus Pharmaceuticals, Inc.

Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases. Neuraltus has two clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig’s disease), Parkinson’s disease and dyskinesias associated with the treatment of Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, as well as lysosomal storage disorders such as Fabry’s disease and Gaucher’s disease.

2483 E. Bayshore Rd., Suite 212, Palo Alto, CA 94303
Tel: 650-424-1600 www.neuraltus.com
Neuraltus Pharmaceuticals, Inc.